CCXI Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (19 Okt 2022 @ 22:00):

Stats
Tagesvolumen	656 224
Durchschnittsvolumen	2.02M
Marktkapitalisierung	0.00
EPS	$-0.450 ( Q2 \| 2022-08-08 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-25.93 (Sector) 42.63 (Industry) 24.32
ATR14	$0.378 (0.73%)

AADI -2.86%

ABCL -2.15%

ABCM 0.04%

ABEO -2.99%

ABIO 2.29%

ABOS -4.46%

ABSI -3.29%

ABUS -0.65%

ABVX -3.34%

ACAD -1.76%

ACER -17.95%

ACET -2.00%

ACGN 1.29%

ACHL 1.43%

ACHV -1.90%

ACIU -3.37%

ACLX -4.07%

ACRV -3.19%

ACST -3.13%

ACXP -4.82%

ADAG -3.08%

ADAP -1.67%

ADGI 0.87%

ADIL -0.87%

ADMA 0.00%

ADPT 3.04%

ADTX 1.13%

ADVM 1.02%

ADXN -1.60%

AEON 5.94%

AEZS 0.22%

AFMD -3.54%

AGEN -2.36%

AGIO -1.19%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA -5.20%

AKRO -1.47%

AKTX -25.54%

AKUS 0.00%

ALBO 0.00%

ALDX 1.22%

ALEC -5.01%

ALGS -6.06%

ALKS -1.83%

ALLK -1.67%

ALLO -8.05%

ALLR -34.80%

ALNA 3.16%

ALNY 7.74%

ALPN 0.02%

ALPX 0.00%

ALRN -1.64%

ALT 3.78%

ALVR -1.01%

ALXN 0.00%

ALXO 0.31%

ALZN -2.08%

AMRN 2.72%

AMTI -3.13%

ANAB -0.83%

ANEB 4.87%

ANGN 0.00%

ANIX -1.20%

ANL -3.22%

ANNX -3.98%

ANPC -3.15%

APGE -3.92%

APGN 8.48%

APGNW 30.65%

APLM -3.77%

APLS 5.15%

APLT -4.10%

APM 1.06%

APOP 0.38%

APRE 0.24%

APTO -1.43%

APTX 3.17%

APVO -6.12%

ARAV -13.39%

ARCT -3.88%

ARDS 2.28%

ARDX -3.68%

ARGX 2.49%

ARNA 0.00%

ARPO -0.90%

ARQT 8.11%

ARTL 11.29%

ARTLW 0.00%

ARVN -2.04%

ARWR -1.36%

ASLN -2.08%

ASMB -1.91%

ASND 4.95%

ATAI -3.57%

ATHA -7.59%

ATHE -0.83%

ATHX -33.50%

ATNF -0.66%

ATOS -3.74%

ATRA -6.10%

ATXI -2.72%

ATXS -1.74%

AUPH -1.59%

AURA -4.22%

AUTL -6.45%

AVBP -2.13%

AVEO 0.00%

AVIR -1.72%

AVRO -1.41%

AVTE -3.33%

AVTX 3.46%

AVXL -3.80%

AXLA 0.00%

AXSM 0.65%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 1.65%

BCAB -1.92%

BCDA 3.53%

BCDAW -39.75%

BCEL 0.00%

BCLI 3.13%

BCRX -3.03%

BCTX -13.88%

BCTXW -4.44%

BCYC -2.58%

BDRX -2.01%

BDTX -3.89%

BEAM -2.34%

BFRA -2.91%

BGNE -5.13%

BIOR -2.10%

BIVI -5.32%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -5.71%

BLTE -0.27%

BLU 0.03%

BLUE -7.08%

BMEA -6.13%

BMRN -0.20%

BNOX -9.25%

BNTC 0.00%

BNTX -2.57%

BOLD -18.11%

BOLT 0.18%

BPMC 0.42%

BPTH 0.48%

BPTS -13.47%

BRNS 0.74%

BRTX 2.91%

BTAI -0.84%

BTTX 1.35%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI -5.22%

CABA -13.47%

CADL -8.13%

CALA 0.00%

CALC 0.00%

CALT -1.18%

CAPR -3.13%

CARA -2.56%

CARM 2.68%

CASI -4.74%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS -5.86%

CCCC 0.00%

CCXI 0.00%

CDAK 0.00%

CDIO -8.01%

CDIOW 24.00%

CDMO -1.53%

CDMOP 0.04%

CDT -15.17%

CDTTW -39.60%

CDTX 5.75%

CDXC -4.31%

CDXS -3.33%

CELC -1.02%

CELU -2.60%

CELUW 11.80%

CERC -1.68%

CERE -4.49%

CERO -14.81%

CEROW 0.60%

CFRX -27.95%

CGEM -5.47%

CGEN -3.21%

CGON -1.47%

CGTX -4.86%

CHMA -6.00%

CHRS -3.07%

CINC 0.00%

CING -3.46%

CINGW 34.95%

CKPT 0.48%

CLBS -16.75%

CLDX 0.11%

CLGN 0.59%

CLLS 1.05%

CLNN -5.91%

CLNNW 0.00%

CLRB -5.59%

CLSD 15.74%

CLSN -0.68%

CLVS 0.00%

CMMB 2.45%

CMND -7.46%

CMPI 0.00%

CMPX -4.50%

CMRA 0.00%

CMRAW 33.33%

CMRX 2.05%

CNCE 0.00%

CNSP 27.35%

CNST 0.00%

CNTA 0.00%

CNTB -3.62%

CNTX 0.46%

COCP -7.20%

COEPW 32.45%

COGT -6.41%

CORT -0.65%

COYA 4.24%

CPRX -1.56%

CRBP 1.93%

CRBU -5.88%

CRDF -4.24%

CRGX -4.30%

CRIS -4.39%

CRNX -1.73%

CRSP -3.43%

CRTX 2.63%

CRVO 0.00%

CRVS -2.73%

CSBR -1.59%

CTCX -11.35%

CTIC 0.06%

CTMX -9.02%

CTNM 3.86%

CTXR 5.10%

CUE -1.70%

CVAC 2.02%

CVKD -2.39%

CWBR 2.80%

CYAD -12.96%

CYCC -4.79%

CYCCP 5.49%

CYCN 5.02%

CYT -2.27%

CYTK -1.91%

CYTO -6.78%

DARE -2.35%

DAWN -0.96%

DBTX -0.81%

DBVT 0.91%

DFFN 10.28%

DICE 0.06%

DMAC 1.80%

DNLI -2.27%

DNTH -5.02%

DOMH 2.16%

DRMA -6.21%

DRMAW -1.25%

DRNA 0.00%

DRTS -1.82%

DRTSW 0.00%

DRUG 5.61%

DSGN -1.49%

DTIL 0.95%

DYAI -3.13%

EARS -1.77%

EDIT -2.17%

EDSA -3.71%

EFTR -1.06%

EFTRW 145.45%

EIGR -9.21%

ELAB -1.03%

ELDN -8.81%

ELEV -1.63%

ELOX -7.14%

ELTX -4.76%

ELVN -1.69%

ELYM -5.28%

ENGN -0.37%

ENGNW 18.81%

ENLV -3.55%

ENOB 1.79%

ENSC -3.98%

ENTA 0.25%

ENTO 1.69%

ENTX -9.22%

ENVB -7.29%

EPIX 0.00%

EPRX -2.97%

EPZM 0.00%

EQ 0.46%

EQRX -2.09%

EQRXW 0.00%

ERAS -3.70%

ERNA -1.64%

ERYP 1.30%

ESLA -0.65%

ESLAW 87.05%

ETNB -6.98%

ETON -1.20%

ETTX 0.00%

EVAX 6.44%

EVGN 0.58%

EVLO 0.00%

EWTX 4.07%

EXAI 0.95%

EXEL -0.27%

EYEG 0.04%

EYEN -2.23%

EYPT -3.05%

FATE -3.13%

FBIO -0.59%

FBIOP 0.32%

FBLG 0.00%

FBRX -6.12%

FDMT -5.38%

FENC -2.36%

FGEN -2.50%

FHTX -1.50%

FIXX 0.77%

FMTX 0.00%

FNCH 8.87%

FOLD -1.30%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE -2.26%

FULC -5.68%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT 4.69%

GANX 0.78%

GBIO 1.43%

GBT 0.01%

GDTC -1.45%

GERN -1.53%

GHRS 0.84%

GLMD -2.79%

GLPG -2.10%

GLSI -0.77%

GLTO -6.44%

GLUE -0.52%

GLYC 25.28%

GMAB -0.15%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -2.81%

GNLX -0.88%

GNPX 0.99%

GNTA 3.94%

GOSS 22.26%

GOVX -27.39%

GOVXW -49.04%

GPCR -8.52%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -3.41%

GRTX 12.03%

GTHX -0.90%

GUTS -9.22%

GXGXW 41.67%

GYRE -3.78%

HALO 0.65%

HARP 0.09%

HCWB -1.65%

HEPA 2.80%

HGEN -84.62%

HILS 5.66%

HLVX -2.68%

HOOK 0.30%

HOTH -4.46%

HOWL -10.34%

HRMY -0.07%

HRTX -4.09%

HSTO 0.00%

HUMA -3.33%

HUMAW 1.27%

IBRX -0.95%

ICCC 0.22%

ICPT 0.21%

ICU -19.90%

ICUCW -13.76%

ICVX -0.91%

IDRA -23.04%

IDYA -2.38%

IFRX -2.99%

IGMS -6.44%

IKNA 0.00%

IKT 0.40%

IMAB 0.00%

IMCR -1.09%

IMGN 0.02%

IMGO 0.00%

IMMP -1.13%

IMMX 1.75%

IMNM -3.35%

IMNN 2.34%

IMPL -27.27%

IMRA 15.96%

IMRN 0.00%

IMRX -4.03%

IMTX -1.64%

IMTXW 6.00%

IMUX -1.82%

IMV 0.00%

IMVT -0.29%

INAB 1.54%

INBX -2.46%

INCY -1.02%

INDP -1.80%

INFI -52.38%

INKT -1.11%

INM -6.35%

INMB -5.05%

INO -3.39%

INSM 1.87%

INTS 0.20%

INVA 0.88%

INZY -2.46%

IOBT 6.72%

IONS 5.19%

IOVA 3.55%

IPA 0.00%

IPHA -1.72%

IPSC -4.48%

IRON -1.04%

ISEE 0.38%

ITOS -1.81%

ITRM 3.42%

IVA 6.96%

IVVD -4.72%

JAGX 0.53%

JANX -4.05%

JAZZ -1.59%

JNCE 0.00%

JSPR -5.33%

JSPRW -16.18%

JUNS 0.00%

JUNSW 0.00%

KA -13.66%

KALV -1.45%

KDNY 0.22%

KMPH -0.34%

KNSA 0.53%

KNTE -0.38%

KOD -7.33%

KPRX 2.21%

KPTI -0.91%

KRBP -10.00%

KRON -6.43%

KROS -1.79%

KRRO -4.81%

KRTX 0.03%

KRYS 1.37%

KTRA 13.76%

KTTA 8.16%

KTTAW 0.92%

KURA -2.80%

KYMR -0.95%

KYTX -1.90%

KZIA -12.30%

KZR 0.97%

LABP 0.57%

LBPH -2.31%

LBPS 0.00%

LBPSW 14.81%

LEGN 1.00%

LENZ -2.43%

LEXX -2.26%

LEXXW -14.63%

LGND -1.33%

LGNDV 0.00%

LGVN -2.08%

LIAN -8.28%

LIFE 2.70%

LIPO -23.38%

LIXT 0.77%

LIXTW -42.57%

LJPC -0.32%

LMNL 0.12%

LOGC 2.68%

LPCN -12.37%

LPTX -3.19%

LQDA -2.54%

LRMR -3.50%

LSTA 3.21%

LTRN 2.56%

LUMO -1.32%

LVTX 3.19%

LXEO -0.76%

LXRX -6.08%

LYEL -3.77%

LYRA -1.79%

MACK 0.10%

MBIO -12.31%

MBRX -0.71%

MCRB -1.11%

MDGL -1.39%

MDNA -13.16%

MDWD 0.55%

MDXG -0.15%

MEIP 2.88%

MESO -0.59%

MGNX -4.67%

MGTA -7.74%

MGTX -1.17%

MGX 3.61%

MIRM -4.91%

MIRO 0.59%

MIST -7.19%

MITO 0.00%

MLEC 7.41%

MLECW 23.81%

MLND -5.36%

MLTX 2.56%

MLYS -3.64%

MNKD -3.50%

MNMD -4.20%

MNOV 2.16%

MNPR 2.63%

MOLN 0.97%

MOR -1.71%

MORF 6.79%

MREO -6.91%

MRKR -1.49%

MRNA 0.44%

MRNS -0.73%

MRSN -4.98%

MRTX -0.17%

MRUS -0.23%

MRVI -2.83%

MTCR -1.29%

MTEM -2.88%

MTP -18.50%

MURA 0.31%

MYMD -1.60%

NAMS 0.20%

NAMSW 0.43%

NAUT 0.67%

NBRV 0.71%

NBSE -1.56%

NBTX 11.93%

NCNA -5.00%

NERV -2.15%

NEXI -1.06%

NGM -1.28%

NGNE -2.05%

NKGN 0.00%

NKGNW 8.00%

NKTR -8.55%

NKTX 9.46%

NLSP -7.12%

NLSPW 26.67%

NMRA -7.89%

NMTR -42.97%

NOVN -24.84%

NRBO 4.41%

NRIX -1.09%

NRSN 1.06%

NRSNW 0.00%

NRXP 0.75%

NRXPW 27.78%

NRXS -2.73%

NTBL -11.13%

NTEC -12.45%

NTHI 0.00%

NTLA -4.00%

NTRBW -31.07%

NUVL -0.30%

NVAX -0.14%

NVCT -1.39%

NVIV -34.28%

NXTC 1.19%

NYMX -0.05%

OABI -6.65%

OABIW -10.06%

OBIO -0.58%

OBSV 0.00%

OCEA 2.16%

OCGN -6.35%

OCS -0.30%

OCUL 0.46%

OCUP -4.38%

ODT -4.27%

OKYO -4.13%

OLMA -1.26%

OMER -4.77%

OMGA -0.83%

ONCO -2.22%

ONCR -3.08%

ONCS 31.87%

ONCT -1.87%

ONCY 0.00%

ONTX -0.47%

ONVO -5.06%

OPNT 0.00%

OPT -1.03%

ORGS -1.66%

ORIC -5.73%

ORMP 0.45%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -3.10%

OVID -11.39%

OYST 0.00%

PALI -3.25%

PASG 0.22%

PBLA 0.00%

PBM -4.22%

PBYI 1.37%

PCSA 6.92%

PCVX -1.69%

PDSB 10.49%

PEPG -6.00%

PGEN 3.73%

PHAR -6.99%

PHAS 0.00%

PHAT -4.62%

PHIO 2.30%

PHIOW 36.47%

PHVS 7.54%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -3.79%

PLUR -5.45%

PMN -5.66%

PMVP -0.59%

PNT 0.16%

PPBT -7.68%

PRAX -6.28%

PRDS 0.93%

PRLD -3.56%

PROG -3.47%

PROK -3.46%

PRQR 0.61%

PRTA -3.84%

PRTC -0.08%

PRTG -5.03%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV 1.86%

PSTX -6.18%

PTCT -1.73%

PTE -0.82%

PTGX -0.94%

PTIXW -5.10%

PULM 2.63%

PXMD -4.59%

PYPD 0.07%

PYXS -4.08%

QLGN -6.58%

QNCX -2.48%

QNRX -4.84%

QSI -2.50%

QSIAW -3.13%

QTTB -3.97%

QURE -1.76%

RAIN -1.63%

RANI -9.00%

RAPT -4.94%

RARE 1.09%

RCKT -0.87%

REGN 0.69%

RENB 1.26%

REPL 0.68%

RETA 0.02%

REUN -0.89%

REVB -10.42%

REVBU 3.46%

REVBW -38.46%

RGLS 4.39%

RGNX -3.67%

RIGL -11.87%

RLAY -2.32%

RLMD -0.33%

RLYB -3.25%

RNA -1.79%

RNAC 4.43%

RNAZ 1.96%

RNXT -1.74%

ROIV -0.73%

ROIVW 4.56%

RPHM -0.62%

RPRX -0.77%

RPTX -3.67%

RUBY 2.70%

RVLP -32.05%

RVMD 0.86%

RVMDW 5.10%

RVNC -8.56%

RVPH -1.56%

RVPHW -3.43%

RXDX 0.09%

RXRX 0.43%

RYTM 0.52%

RYZB 0.02%

RZLT -9.15%

SABS 0.00%

SABSW 0.25%

SAGE -5.71%

SANA -2.17%

SAVA -2.58%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI -8.04%

SCPH -2.94%

SCPS 0.00%

SEEL 2.13%

SEER -1.73%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -4.94%

SGMT -1.43%

SGTX -2.56%

SIOX 22.63%

SLDB -12.39%

SLGL 8.36%

SLN -2.01%

SLNO -2.84%

SLRX 1.24%

SLS -3.31%

SMMT 0.13%

SNDX -1.31%

SNGX -21.60%

SNPX -3.13%

SONN -0.33%

SPPI -0.49%

SPRB 3.68%

SPRC -2.37%

SPRO 0.00%

SRNE -9.09%

SRPT -3.53%

SRRA 0.00%

SRRK -4.04%

SRZN -2.45%

STAB 0.00%

STOK -2.65%

STRO -2.61%

STSA 0.00%

STTK -10.11%

SURF -0.93%

SVRA 3.83%

SWTX 0.94%

SYBX 1.97%

SYRS -0.17%

TALS -0.73%

TARA -5.83%

TARS -2.36%

TBPH -4.22%

TCBP -9.85%

TCDA 0.00%

TCON 21.14%

TCRR 0.00%

TCRT -3.63%

TCRX -7.47%

TECH -1.91%

TENX 3.88%

TERN -3.59%

TFFP 3.68%

TGTX 4.24%

THRX 0.12%

TIL 0.00%

TLC 0.00%

TLSA 2.32%

TNGX -8.77%

TNXP 5.04%

TNYA -7.61%

TPST -1.44%

TRDA 3.72%

TRVI -1.14%

TRVN -2.41%

TSHA -7.33%

TSVT -2.59%

TTNP -0.91%

TVTX 2.18%

TYRA -0.88%

UBX 0.36%

UNCY -26.76%

URGN -5.61%

UTHR 0.03%

VACC 11.36%

VALN -4.35%

VAXX -5.88%

VBIV 3.23%

VBLT -8.77%

VCEL -2.81%

VCNX -6.47%

VCYT -0.92%

VERA 0.97%

VERU -6.67%

VERV -0.95%

VIGL -4.12%

VINC -3.01%

VIR 0.66%

VIRI -5.96%

VIRX -3.22%

VKTX -8.29%

VLON -13.04%

VNDA 2.68%

VOR 0.00%

VRCA -0.98%

VRDN -3.41%

VRNA -4.14%

VRPX -2.58%

VRTX -0.24%

VSTM -5.16%

VTGN 2.79%

VTVT -6.43%

VTYX -4.02%

VXRT -7.63%

VYGR -2.92%

VYNE 0.00%

VYNT 7.78%

WINT -3.24%

WVE -8.45%

XBIO -8.15%

XBIT 5.73%

XCUR -4.08%

XENE -1.10%

XERS -0.47%

XFOR -4.95%

XLO -3.30%

XLRN 0.00%

XNCR -3.68%

XOMA -5.07%

XOMAO 0.36%

XOMAP 0.73%

XRTX -3.29%

YMAB 1.16%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -1.23%

ZNTL -8.70%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2022-10-20	Jain Rita	Sell	11 600	Restricted Stock Unit
2022-10-20	Herron Jennifer Lyn	Sell	17 237	Common Stock
2022-10-20	Edwards Thomas A.	Sell	15 723	Restricted Stock Unit
2022-10-20	Parker Geoffrey M.	Sell	15 723	Restricted Stock Unit
2022-10-20	Kanaya Susan M	Sell	90 968	Restricted Stock Unit

INSIDER POWER
-78.69
Last 97 transactions
Buy: 1 451 999 \| Sell: 1 420 462

Volumen Korrelation

Lang: 0.21 (neutral)

Kurz: 0.67 (moderate)

Signal:(79.007) Neutral

ChemoCentryx, Inc. Korrelation

10 Am meisten positiv korreliert
SANB	0.835

10 Am meisten negativ korreliert

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

ChemoCentryx, Inc. Korrelation - Währung/Rohstoff

0.58
( weak )

0.22
( neutral )

0.71
( moderate )

0.47
( neutral )

0.01
( neutral )

-0.87
( strong negative )

ChemoCentryx, Inc. Finanzdaten

Annual	2021
Umsatz:	$32.22M
Bruttogewinn:	$31.92M (99.06 %)
EPS:	$-1.890

FY	2021
Umsatz:	$32.22M
Bruttogewinn:	$31.92M (99.06 %)
EPS:	$-1.890

FY	2020
Umsatz:	$64.89M
Bruttogewinn:	$64.89M (100.00 %)
EPS:	$-0.840

FY	2019
Umsatz:	$35.95M
Bruttogewinn:	$0.00 (0.00 %)
EPS:	$-0.980

Financial Reports:

No articles found.

ChemoCentryx, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

ChemoCentryx, Inc.

ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil cytoplasmic autoantibody-associated vasculitis. The company also develops TAVNEOS for the treatment of patients with severe hidradenitis suppurativa, as well as patients with complement 3 glomerulopathy, and lupus nephritis. In addition, it develops CCX559, an orally administered inhibitor for programmed death protein 1/programmed death-ligand 1 for the treatment of various cancers; and CCX507, an orally administered inhibitor of the chemokine receptor known as CCR9, which has completed Phase I clinical trial for the treatment of inflammatory bowel disease. Further, the company has early-stage drug candidates that targets Th17 driven diseases and CCR6. ChemoCentryx, Inc. was incorporated in 1996 and is headquartered in San Carlos, California. As of October 20, 2022, ChemoCentryx, Inc. operates as a subsidiary of Amgen Inc.